406 related articles for article (PubMed ID: 37492224)
101. Natural and herbal compounds targeting breast cancer, a review based on cancer stem cells.
Bozorgi A; Khazaei S; Khademi A; Khazaei M
Iran J Basic Med Sci; 2020 Aug; 23(8):970-983. PubMed ID: 32952942
[TBL] [Abstract][Full Text] [Related]
102. Abnormal Glycosylation of Cancer Stem Cells and Targeting Strategies.
Khan T; Cabral H
Front Oncol; 2021; 11():649338. PubMed ID: 33889547
[TBL] [Abstract][Full Text] [Related]
103. Signaling pathways governing the behaviors of leukemia stem cells.
Azizidoost S; Nasrolahi A; Sheykhi-Sabzehpoush M; Anbiyaiee A; Khoshnam SE; Farzaneh M; Uddin S
Genes Dis; 2024 Mar; 11(2):830-846. PubMed ID: 37692500
[TBL] [Abstract][Full Text] [Related]
104. Stem Cells, Self-Renewal, and Lineage Commitment in the Endocrine System.
Mariniello K; Ruiz-Babot G; McGaugh EC; Nicholson JG; Gualtieri A; Gaston-Massuet C; Nostro MC; Guasti L
Front Endocrinol (Lausanne); 2019; 10():772. PubMed ID: 31781041
[TBL] [Abstract][Full Text] [Related]
105. Editorial: New insights in cellular and molecular biology of cancer stem cells.
Vazquez-Santillan K; Bustamante-Marin X; Ortiz-Sanchez E
Front Genet; 2023; 14():1297971. PubMed ID: 37849502
[No Abstract] [Full Text] [Related]
106. Hypoxia: syndicating triple negative breast cancer against various therapeutic regimens.
Srivastava N; Usmani SS; Subbarayan R; Saini R; Pandey PK
Front Oncol; 2023; 13():1199105. PubMed ID: 37492478
[TBL] [Abstract][Full Text] [Related]
107. Cellular mechanotransduction in health and diseases: from molecular mechanism to therapeutic targets.
Di X; Gao X; Peng L; Ai J; Jin X; Qi S; Li H; Wang K; Luo D
Signal Transduct Target Ther; 2023 Jul; 8(1):282. PubMed ID: 37518181
[TBL] [Abstract][Full Text] [Related]
108. Cancer cell plasticity during tumor progression, metastasis and response to therapy.
Pérez-González A; Bévant K; Blanpain C
Nat Cancer; 2023 Aug; 4(8):1063-1082. PubMed ID: 37537300
[TBL] [Abstract][Full Text] [Related]
109. Natural killer cell therapy targeting cancer stem cells: Old wine in a new bottle.
Guo F; Zhang Y; Bai L; Cui J
Cancer Lett; 2023 Aug; 570():216328. PubMed ID: 37499742
[TBL] [Abstract][Full Text] [Related]
110. The Hippo/YAP signaling pathway: the driver of cancer metastasis.
Zhou T; Li X; Liu J; Hao J
Cancer Biol Med; 2023 Jul; 20(7):483-9. PubMed ID: 37493303
[No Abstract] [Full Text] [Related]
111. The SIRT1-c-Myc axis in regulation of stem cells.
Fan W; Li X
Front Cell Dev Biol; 2023; 11():1236968. PubMed ID: 37554307
[TBL] [Abstract][Full Text] [Related]
112. S100 proteins in head and neck squamous cell carcinoma (Review).
Hu Y; Han Y; He M; Zhang Y; Zou X
Oncol Lett; 2023 Aug; 26(2):362. PubMed ID: 37545618
[TBL] [Abstract][Full Text] [Related]
113. Influence of technical and maternal-infant factors on the measurement and expression of extracellular miRNA in human milk.
Holzhausen EA; Kupsco A; Chalifour BN; Patterson WB; Schmidt KA; Mokhtari P; Baccarelli AA; Goran MI; Alderete TL
Front Immunol; 2023; 14():1151870. PubMed ID: 37492577
[TBL] [Abstract][Full Text] [Related]
114. Breast cancer stem cells, heterogeneity, targeting therapies and therapeutic implications.
Zeng X; Liu C; Yao J; Wan H; Wan G; Li Y; Chen N
Pharmacol Res; 2021 Jan; 163():105320. PubMed ID: 33271295
[TBL] [Abstract][Full Text] [Related]
115. Signaling pathways governing breast cancer stem cells behavior.
Song K; Farzaneh M
Stem Cell Res Ther; 2021 Apr; 12(1):245. PubMed ID: 33863385
[TBL] [Abstract][Full Text] [Related]
116. Mechanistic Pathways of Malignancy in Breast Cancer Stem Cells.
Yousefnia S; Seyed Forootan F; Seyed Forootan S; Nasr Esfahani MH; Gure AO; Ghaedi K
Front Oncol; 2020; 10():452. PubMed ID: 32426267
[TBL] [Abstract][Full Text] [Related]
117. Breast cancer stem cells and the challenges of eradication: a review of novel therapies.
Saeg F; Anbalagan M
Stem Cell Investig; 2018; 5():39. PubMed ID: 30498750
[TBL] [Abstract][Full Text] [Related]
118. Breast cancer stem cells, pathways and therapeutic perspectives 2011.
Nigam A
Indian J Surg; 2013 Jun; 75(3):170-80. PubMed ID: 24426422
[TBL] [Abstract][Full Text] [Related]
119. Signaling pathways governing the maintenance of breast cancer stem cells and their therapeutic implications.
Ordaz-Ramos A; Tellez-Jimenez O; Vazquez-Santillan K
Front Cell Dev Biol; 2023; 11():1221175. PubMed ID: 37492224
[TBL] [Abstract][Full Text] [Related]
120.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
